F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Moderna said it had further discussions with regulators and announced that the agency would grant the company’s request for approval of its flu vaccine that uses mRNA technology.
